Navigation Links
Segal Trials Screens its First Patient in a study of Psilocybin for Major Depressive Disorder

Segal Trials, a privately held network of research sites throughout South Florida and South Carolina conducting Phase I-IV trials, is excited to announce the screening of its first patient for a Phase 2 clinical trial (Usona PSIL201) investigating the safety and efficacy of psilocybin for major depressive disorder (MDD).

Dr. Rishi Kakar and his clinical research team, at Segal Trials, at our West Broward Outpatient site will be spearheading this trial for the organization. The Usona study will use a randomized, double-blinded, placebo-controlled design to evaluate the potential antidepressant effects of a single dose of psilocybin in patients with MDD.

The Usona Institute received Breakthrough Therapy Designation from the FDA for the use of psilocybin in the treatment of major depressive disorder. There are over 17 million people in the United States who suffer from major depression, and this breakthrough designation is important as it addresses an unmet need and offers another option that may allow a clinically significant improvement over other therapies on the market.

Data suggest that psilocybin may have behavioral effects relevant to the treatment of depression and recent studies also suggest that psilocybin may possess antidepressant properties. To further assess the effects of psilocybin on MDD signs and symptoms, this trial will assess the safety and efficacy of psilocybin on 80 individuals suffering from MDD at seven sites within the US. Dr. Kakar, of Segal Trials, is proud to be one of these sites, exploring this new breakthrough treatment for depression.

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related medicine news :

1. Segal Institute For Clinical Research Announces Company Name Change to Segal Trials
2. Dr. Eric Segal, Director of the Northeast Regional Epilepsy Group Pediatric Epilepsy Program in NJ Is Invited to Present at the 2016 Dravet Syndrome Foundation
3. The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital
4. Mercy Medical Center Announces Opening of New Lya Segall Ovarian Cancer Institute
5. The 25th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital
6. LaRocca Skincare Launches in New Beauty at Fred Segal Santa Monica
7. TrialScope Launches Clinical Trials Website for EMD Serono
8. How Do Visual Patient Profiles Help Medical Reviews in Complex Oncology Trials? — A New Webinar Hosted by Xtalks
9. Customers Over Data – Implementing BYOD Across Phase II and III Clinical Trials, New Webinar Hosted by Xtalks
10. Regular Consumption of Dietary Peanut Possible Years After Immunotherapy Trials
11. Advanced Clinical Announces New Office Location at Partnerships in Clinical Trials Europe
Post Your Comments:
(Date:6/24/2020)... ... June 24, 2020 , ... SPH Analytics , ... Physician Hospital Organization (PHO) has successfully deployed SPH’s Population Care™ all-payer population health ... value-based care. Use of Population Care is benefitting more than 77,000 patients covered ...
(Date:6/24/2020)... ... June 24, 2020 , ... Skyroam , the developer ... with LabWare , the leading provider of enterprise software for testing laboratories, in ... part of LabWare’s new Portable Disease Surveillance Lab (PDSL) kit. , “Stopping the spread ...
(Date:6/23/2020)... ... June 23, 2020 , ... Oak Street Health, a network of primary ... for nationwide expansion in 2020 with the company’s first centers in New York and ... in Brooklyn, N.Y., and a new center in Jackson, Miss. , “The planned ...
(Date:6/23/2020)... Columbia (PRWEB) , ... June 23, 2020 , ... ... Dr. Mike Hart has been named as the President of North America’s ... experience in plant based therapy, including owning and operating his own family medicine clinic ...
(Date:6/23/2020)... Va. (PRWEB) , ... June 22, 2020 , ... In ... updated market sizes and forecasts for the market for tests tied to therapeutic selection ... oncology treatment centers in hospitals, as well as pharmaceutical companies serving them to determine ...
Breaking Medicine News(10 mins):
(Date:7/2/2020)... , ... July 02, 2020 , ... ... at Medical Conditions that Chiropractors Treat. , “From migraines to anxiety to ... medical conditions,” according to the company. , Sourced from physician recommendations on ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... (PDT) for treating cancer, today announced the formation of its Scientific Advisory Board ... provide critical medical, scientific, and strategic advice to support company development and introduction ...
(Date:6/25/2020)... ... 2020 , ... R3 Medical Training announced today it is now enrolling for ... The first course is August 6-7, 2020 in San Diego and the second is ... Virtual Live Stream option. , The two day agenda for each course is identical, ...
Breaking Medicine Technology: